
|Videos|January 19, 2017
Drug Cost Growth Changing the Specialty Pharmacy Patient Experience
Author(s)Lauren Santye, Assistant Editor
Marc O'Connor, CEO and chief strategy officer of Curant Health, discusses how projected drug spending growth will alter the specialty pharmacy landscape in the future.
Advertisement
Marc O'Connor, CEO and chief strategy officer of Curant Health, discusses how projected drug spending growth will alter the specialty pharmacy landscape in the future.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
Modern Therapies Challenge Radiation’s Role in Early Breast Cancer Survival
3
FDA Approves Lumateperone With Antidepressant Use for Major Depressive Disorder
4
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
5












































































































































































































